Cronos Group (CRON) Financials: History & Chart

Cronos Group Inc.(CRON)

Drug Manufacturers - Specialty & Generic · Stayner, ON

$3.27+0.02 (+0.46%)

Delayed quote: Oct 6, 2026, 1:44 PM EDT

About Cronos Group Inc.

Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.

Stayner, ON

610 employees

www.thecronosgroup.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Michael Ryan Gorenstein

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	225.24M	53.01M	44.58M	91.31M	36.34M	33.45M	32.26M	30.30M	34.26M
Cost of Goods Sold	143.80M	24.56M	26.12M	75.12M	18.01M	18.95M	18.53M	19.49M	30.65M
Gross Profit	81.44M	28.45M	18.47M	16.19M	18.33M	14.50M	13.73M	10.81M	3.61M
Gross Profit Margin	36.2%	53.7%	41.4%	17.7%	50.4%	43.4%	42.6%	35.7%	10.5%
Total Operating Expenses	68.80M	20.85M	19.90M	9.22M	18.84M	19.83M	17.81M	22.17M	37.27M
Research & Development	5.34M	1.22M	1.39M	1.38M	1.34M	929K	793K	1.03M	1.24M
Selling, General & Administrative	67.03M	19.14M	17.35M	13.65M	16.89M	17.26M	15.96M	20.68M	20.55M
Operating Income (EBIT)	12.64M	7.60M	-1.43M	6.97M	-503K	-5.32M	-4.07M	-11.37M	-33.66M
Operating Margin	5.6%	14.3%	-3.2%	7.6%	-1.4%	-15.9%	-12.6%	-37.5%	-98.2%
Income Before Tax (EBT)	68.22M	35.71M	17.89M	-12.39M	27.00M	-39.01M	7.27M	45.95M	4.62M
Interest Income	38.99M	8.82M	8.73M	9.71M	11.74M	9.15M	9.66M	11.86M	12.46M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	55.58M	28.11M	19.32M	-19.36M	27.51M	-33.68M	11.34M	57.31M	38.27M
Net Income	69.79M	32.09M	13.56M	-1.82M	25.96M	-39.71M	6.12M	43.73M	8.35M
Income Tax Expense	-10.77M	51K	2.39M	-11.89M	-1.32M	-525K	-455K	2.00M	-2.71M
Net Profit Margin	31.0%	60.5%	30.4%	-2.0%	71.4%	-118.7%	19.0%	144.3%	24.4%
EBITDA	27.12M	10.98M	2.24M	10.88M	3.03M	-1.12M	-1.23M	-9.33M	-30.09M
EBITDA Margin	12.0%	20.7%	5.0%	11.9%	8.3%	-3.4%	-3.8%	-30.8%	-87.8%
Depreciation & Amortization	14.49M	3.37M	3.68M	3.91M	3.53M	4.20M	2.84M	2.04M	3.57M
EPS Basic	0.18	0.08	0.04	-0.00	0.07	-0.10	0.02	0.12	0.02
EPS Diluted	0.18	0.08	0.04	-0.00	0.07	-0.10	0.02	0.11	0.02
Weighted Average Basic Shares	385.31M	385.31M	385.31M	385.31M	385.31M	385.31M	382.96M	382.34M	382.29M
Weighted Average Diluted Shares	385.31M	385.31M	385.31M	385.31M	385.31M	385.31M	386.96M	386.52M	385.98M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	149.15M	117.61M	87.24M	86.75M	64.56M	46.72M	17.84M	8.88M
Cost of Goods Sold	87.45M	92.42M	75.33M	71.31M	82.15M	72.55M	31.05M	4.33M
Gross Profit	61.70M	25.20M	11.91M	15.44M	-17.59M	-25.83M	-13.22M	4.55M
Gross Profit Margin	41.4%	21.4%	13.7%	17.8%	-27.3%	-55.3%	-74.1%	51.3%
Total Operating Expenses	79.54M	101.73M	96.71M	126.86M	274.38M	193.55M	101.93M	19.53M
Research & Development	4.45M	4.23M	5.84M	13.13M	21.84M	20.37M	9.13M	1.26M
Selling, General & Administrative	63.76M	76.82M	80.93M	100.73M	121.68M	130.32M	87.23M	17.61M
Operating Income (EBIT)	-17.84M	-76.53M	-84.80M	-111.43M	-291.97M	-219.39M	-118.47M	-14.98M
Operating Margin	-12.0%	-65.1%	-97.2%	-128.4%	-452.2%	-469.6%	-664.2%	-168.7%
Income Before Tax (EBT)	-17.42M	36.59M	-73.67M	-121.00M	-128.51M	-73.27M	875.69M	-15.33M
Interest Income	40.66M	52.02M	51.23M	22.51M	9.07M	18.60M	21.49M	79K
Interest Expense	N/A	N/A	N/A	13K	27K	186K	24.75M	N/A
Other Income/Expense	419K	113.11M	11.13M	-9.57M	163.46M	146.11M	990.84M	-350K
Net Income	-9.61M	41.08M	-73.96M	-168.73M	-396.11M	-73.14M	1.19B	-15.85M
Income Tax Expense	-14.44M	-3.44M	-3.23M	34.17M	-431K	1.35M	0.00	0.00
Net Profit Margin	-6.4%	34.9%	-84.8%	-194.5%	-613.5%	-156.5%	6691.6%	-178.5%
EBITDA	-3.36M	-67.19M	-76.69M	-98.31M	-276.57M	-212.34M	-115.26M	-13.56M
EBITDA Margin	-2.3%	-57.1%	-87.9%	-113.3%	-428.4%	-454.5%	-646.2%	-152.7%
Depreciation & Amortization	14.48M	9.34M	8.11M	13.12M	15.40M	7.04M	3.21M	1.42M
EPS Basic	-0.03	0.11	-0.19	-0.45	-1.07	-0.21	3.76	-0.11
EPS Diluted	-0.03	0.11	-0.19	-0.45	-1.07	-0.21	3.41	-0.11
Weighted Average Basic Shares	385.31M	382.06M	380.96M	376.96M	370.39M	351.58M	310.07M	172.27M
Weighted Average Diluted Shares	385.31M	385.56M	380.96M	376.96M	370.39M	351.58M	342.81M	172.27M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.